• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于荧光的方法对肺癌患者血浆中总DNA与可扩增DNA定量的评估。

Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.

作者信息

Szpechcinski A, Struniawska R, Zaleska J, Chabowski M, Orlowski T, Roszkowski K, Chorostowska-Wynimko J

机构信息

Laboratory of Molecular Diagnostics, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.

出版信息

J Physiol Pharmacol. 2008 Dec;59 Suppl 6:675-81.

PMID:19218694
Abstract

In the last decade numerous reports demonstrated that free-circulating DNA in plasma/serum samples might be a promising biomarker in a number of pathologies, including cancer. Thus, choosing the reliable and efficient method of plasma DNA quantification would be an essential step prior to any clinical evaluation of cell-free DNA measurement in cancer patients. The aim of present study was to compare two highly-sensitive DNA quantification methods in regard to their applicability and effectiveness in monitoring the cell-free DNA level in the blood of patients with resectable non-small cell lung cancer. Plasma samples collected from 10 patients before any treatment, after neoadjuvant therapy and subsequent surgery, were used for DNA quantification by direct fluorescent PicoGreen staining and by real-time qPCR in SYBR Green and TaqMan probe approach using beta-actin gene as the amplifying target. The PicoGreen method demonstrated a high level of correlation with both the SYBR Green (r=0.87, P<0.0001) and TaqMan probe approach (r=0.94, P<0.0001). The total DNA content, determined by PicoGreen, proved to be several-fold higher than the amplifiable DNA amount measured by real-time qPCR. Consequently, intercalating fluorochromes, like PicoGreen, might serve as a rapid, accurate, and inexpensive alternative to real-time qPCR for routine dsDNA quantification and multicenter standardization.

摘要

在过去十年中,大量报告表明,血浆/血清样本中的游离循环DNA可能是包括癌症在内的多种疾病中有前景的生物标志物。因此,在对癌症患者的游离DNA测量进行任何临床评估之前,选择可靠且高效的血浆DNA定量方法将是至关重要的一步。本研究的目的是比较两种高灵敏度DNA定量方法在监测可切除非小细胞肺癌患者血液中游离DNA水平方面的适用性和有效性。从10例患者在任何治疗前、新辅助治疗后及随后手术前后采集的血浆样本,用于通过直接荧光PicoGreen染色以及使用β-肌动蛋白基因作为扩增靶点的SYBR Green和TaqMan探针法的实时定量PCR进行DNA定量。PicoGreen方法与SYBR Green(r = 0.87,P < 0.0001)和TaqMan探针法(r = 0.94,P < 0.0001)均显示出高度相关性。通过PicoGreen测定的总DNA含量被证明比通过实时定量PCR测量的可扩增DNA量高出几倍。因此,像PicoGreen这样的嵌入荧光染料可能作为实时定量PCR的一种快速、准确且廉价的替代方法,用于常规双链DNA定量和多中心标准化。

相似文献

1
Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.基于荧光的方法对肺癌患者血浆中总DNA与可扩增DNA定量的评估。
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:675-81.
2
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.循环血浆DNA作为非小细胞肺癌的诊断生物标志物
Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19.
3
Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.循环脱氧核糖核酸作为接受化疗的非小细胞肺癌患者的预后标志物。
J Clin Oncol. 2004 Oct 15;22(20):4157-64. doi: 10.1200/JCO.2004.11.123.
4
Quantification of free circulating DNA as a diagnostic marker in lung cancer.游离循环DNA作为肺癌诊断标志物的定量分析
J Clin Oncol. 2003 Nov 1;21(21):3902-8. doi: 10.1200/JCO.2003.02.006. Epub 2003 Sep 24.
5
T cell receptor BV repertoires using real time PCR: a comparison of SYBR green and a dual-labelled HuTrec fluorescent probe.使用实时PCR分析T细胞受体BV谱系:SYBR Green与双标记HuTrec荧光探针的比较
J Immunol Methods. 2004 Nov;294(1-2):43-52. doi: 10.1016/j.jim.2004.08.015. Epub 2004 Oct 6.
6
Quantification of plasma cell-free DNA in patients with gastric cancer.胃癌患者血浆游离DNA的定量分析
Anticancer Res. 2007 Jul-Aug;27(4C):2747-51.
7
Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer.循环血浆DNA片段作为食管癌患者肿瘤标志物的定量分析。
Anticancer Res. 2007 Jul-Aug;27(4C):2737-41.
8
A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids.一种用于生物体液中游离 DNA 定量的快速直接荧光检测法。
Ann Clin Biochem. 2009 Nov;46(Pt 6):488-94. doi: 10.1258/acb.2009.009002. Epub 2009 Sep 3.
9
Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.肿瘤患者血浆中循环DNA半定量检测的可重复性
J Clin Oncol. 2005 May 1;23(13):3163-4; author reply 3164-5. doi: 10.1200/JCO.2005.05.430.
10
Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.使用实时聚合酶链反应对卵巢癌患者血浆游离DNA进行定量分析。
Ann N Y Acad Sci. 2006 Sep;1075:230-4. doi: 10.1196/annals.1368.031.

引用本文的文献

1
Applying the concept of liquid biopsy to monitor the microbial biodiversity of marine coastal ecosystems.应用液体活检概念监测海洋沿岸生态系统的微生物生物多样性。
ISME Commun. 2022 Jul 27;2(1):61. doi: 10.1038/s43705-022-00145-0.
2
Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk.全基因组关联研究和基因表达分析提示 ORM1 可能是循环游离 DNA 水平和血栓形成风险的潜在调节因子。
Thromb Haemost. 2022 Jun;122(6):1027-1039. doi: 10.1055/s-0041-1742169. Epub 2022 Mar 10.
3
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine.
乳腺癌中的循环游离DNA:探寻精准医学的隐藏信息
Cancers (Basel). 2021 Feb 10;13(4):728. doi: 10.3390/cancers13040728.
4
Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma.游离DNA作为弥漫性大B细胞淋巴瘤患者预后生物标志物的临床意义
Blood Res. 2019 Jun;54(2):114-119. doi: 10.5045/br.2019.54.2.114. Epub 2019 Jun 25.
5
Plasma cell-free DNA: a potential biomarker for early prediction of severe dengue.血浆无细胞游离 DNA:一种用于早期预测重症登革热的潜在生物标志物。
Ann Clin Microbiol Antimicrob. 2019 Mar 13;18(1):10. doi: 10.1186/s12941-019-0309-x.
6
Temporal patterns of circulating cell-free DNA (cfDNA) in a newborn piglet model of perinatal asphyxia.围产期窒息新生仔猪模型中循环游离 DNA(cfDNA)的时间模式。
PLoS One. 2018 Nov 26;13(11):e0206601. doi: 10.1371/journal.pone.0206601. eCollection 2018.
7
Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literature.影响游离循环DNA质量和产量的因素:方法学文献的系统综述
Heliyon. 2018 Jul 25;4(7):e00699. doi: 10.1016/j.heliyon.2018.e00699. eCollection 2018 Jul.
8
Efficacy of assessing circulating cell-free DNA using a simple fluorescence assay in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a prospective observational study.采用简单荧光检测法评估接受新辅助化疗的三阴性乳腺癌患者循环游离DNA的疗效:一项前瞻性观察研究。
Oncotarget. 2017 Dec 21;9(3):3875-3886. doi: 10.18632/oncotarget.23520. eCollection 2018 Jan 9.
9
Development and Evaluation of a Duplex Real-Time PCR Assay With a Novel Internal Standard for Precise Quantification of Plasma DNA.一种用于精确定量血浆DNA的新型内标双链实时PCR检测方法的开发与评估。
Ann Lab Med. 2017 Jan;37(1):18-27. doi: 10.3343/alm.2017.37.1.18.
10
Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests.早期、小体积且甲胎蛋白阴性原发性肝癌的简易可靠诊断:血清荧光与传统血液检测的综合方法
Oncotarget. 2016 Sep 27;7(39):64053-64070. doi: 10.18632/oncotarget.11771.